FMR LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 72 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$13,440
+168.8%
6,400
+60.0%
0.00%
Q2 2022$5,000
+66.7%
4,000
+97.5%
0.00%
Q1 2022$3,0002,025
+4400.0%
0.00%
Q4 2021$0450.0%0.00%
Q3 2021$045
+4400.0%
0.00%
Q2 2021$0
-100.0%
1
-99.9%
0.00%
Q1 2021$3,0001,500
+9275.0%
0.00%
Q3 2019$0160.0%0.00%
Q2 2019$0
-100.0%
16
-98.0%
0.00%
Q4 2018$3,000
-40.0%
8000.0%0.00%
Q3 2018$5,0008000.00%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$401,0000.10%
Geneos Wealth Management Inc. 511,606$2,261,0000.06%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$26,0000.01%
OCCUDO QUANTITATIVE STRATEGIES LP 18,967$41,0000.01%
Vivaldi Capital Management LP 10,668$45,0000.01%
OSAIC HOLDINGS, INC. 1,221,984$2,651,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$34,0000.00%
WEDBUSH SECURITIES INC 17,998$39,0000.00%
D.A. DAVIDSON & CO. 65,310$142,0000.00%
Virtu Financial LLC 14,683$32,0000.00%
View complete list of GALECTIN THERAPEUTICS INC shareholders